This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Reviewing the potential of Otsuka/Recor Medicals Paradise ultrasound renal denervation (RDN) system for high blood pressure

Ticker(s): OTSKY, MDT, ReCor Medical

Who's the expert?

Institution: NYU Langone

  • Interventional Cardiologist at NYU Langone Medical Centers and Chinatown Cardiology
  • Treats 210 patients with atrial fibrillation at moderate-to-high risk of stroke and 75 patients with resistant hypertension
  • clinical expertise is in performing transradial cardiac catheterization, peripheral endovascular intervention, percutaneous mitral & aortic valvuloplasty, and ASD/PFO closure. 

Interview Questions
Q1.

Please describe your background and practice setting

Added By: ben_admin
Q2.

How many patients with high BP do you manage?

Added By: ben_admin
Q3.

What are your thoughts on the recent FDA approval of the Paradise renal denervation system?

Added By: ben_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.